nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—CYP3A4—bone cancer	0.202	1	CbGaD
Cyclosporine—ABCC10—Doxorubicin—bone cancer	0.0539	0.0955	CbGbCtD
Cyclosporine—ABCC10—Methotrexate—bone cancer	0.0522	0.0925	CbGbCtD
Cyclosporine—ABCC3—Cisplatin—bone cancer	0.0506	0.0896	CbGbCtD
Cyclosporine—ABCC1—Epirubicin—bone cancer	0.0391	0.0694	CbGbCtD
Cyclosporine—ABCC3—Doxorubicin—bone cancer	0.0339	0.0601	CbGbCtD
Cyclosporine—ABCC3—Methotrexate—bone cancer	0.0328	0.0582	CbGbCtD
Cyclosporine—ABCB11—Doxorubicin—bone cancer	0.0293	0.0519	CbGbCtD
Cyclosporine—ABCC2—Carboplatin—bone cancer	0.0269	0.0477	CbGbCtD
Cyclosporine—ABCG2—Carboplatin—bone cancer	0.0243	0.0431	CbGbCtD
Cyclosporine—ABCC2—Cisplatin—bone cancer	0.023	0.0407	CbGbCtD
Cyclosporine—ABCC1—Doxorubicin—bone cancer	0.0208	0.0369	CbGbCtD
Cyclosporine—ABCG2—Cisplatin—bone cancer	0.0208	0.0368	CbGbCtD
Cyclosporine—ABCC1—Methotrexate—bone cancer	0.0202	0.0357	CbGbCtD
Cyclosporine—SLCO1A2—Methotrexate—bone cancer	0.018	0.0319	CbGbCtD
Cyclosporine—SLCO1B1—Methotrexate—bone cancer	0.017	0.0301	CbGbCtD
Cyclosporine—ABCC2—Doxorubicin—bone cancer	0.0154	0.0273	CbGbCtD
Cyclosporine—ABCC2—Methotrexate—bone cancer	0.0149	0.0264	CbGbCtD
Cyclosporine—ABCG2—Doxorubicin—bone cancer	0.0139	0.0247	CbGbCtD
Cyclosporine—ABCG2—Methotrexate—bone cancer	0.0135	0.0239	CbGbCtD
Cyclosporine—SLC22A6—Methotrexate—bone cancer	0.0109	0.0194	CbGbCtD
Cyclosporine—CYP2C9—Cisplatin—bone cancer	0.00772	0.0137	CbGbCtD
Cyclosporine—ABCB1—Cisplatin—bone cancer	0.00749	0.0133	CbGbCtD
Cyclosporine—ABCB1—Doxorubicin—bone cancer	0.00502	0.0089	CbGbCtD
Cyclosporine—ABCB1—Methotrexate—bone cancer	0.00486	0.00862	CbGbCtD
Cyclosporine—CYP2D6—Doxorubicin—bone cancer	0.00473	0.00839	CbGbCtD
Cyclosporine—CYP3A4—Doxorubicin—bone cancer	0.00301	0.00533	CbGbCtD
Cyclosporine—FKBP4—connective tissue—bone cancer	0.000504	0.0631	CbGeAlD
Cyclosporine—FKBP4—tendon—bone cancer	0.000346	0.0434	CbGeAlD
Cyclosporine—FKBP4—spinal cord—bone cancer	0.000334	0.0418	CbGeAlD
Cyclosporine—PPP3CA—connective tissue—bone cancer	0.000324	0.0405	CbGeAlD
Cyclosporine—PPIB—connective tissue—bone cancer	0.000322	0.0403	CbGeAlD
Cyclosporine—PPID—tendon—bone cancer	0.00032	0.04	CbGeAlD
Cyclosporine—CAMLG—tendon—bone cancer	0.000315	0.0394	CbGeAlD
Cyclosporine—PPID—bone marrow—bone cancer	0.000309	0.0388	CbGeAlD
Cyclosporine—PPID—spinal cord—bone cancer	0.000308	0.0386	CbGeAlD
Cyclosporine—CAMLG—bone marrow—bone cancer	0.000305	0.0382	CbGeAlD
Cyclosporine—CAMLG—spinal cord—bone cancer	0.000304	0.038	CbGeAlD
Cyclosporine—PPIA—tendon—bone cancer	0.000287	0.0359	CbGeAlD
Cyclosporine—PPIA—bone marrow—bone cancer	0.000278	0.0348	CbGeAlD
Cyclosporine—PPIA—spinal cord—bone cancer	0.000277	0.0346	CbGeAlD
Cyclosporine—PPIF—tendon—bone cancer	0.000232	0.0291	CbGeAlD
Cyclosporine—PPIF—bone marrow—bone cancer	0.000225	0.0282	CbGeAlD
Cyclosporine—PPIF—spinal cord—bone cancer	0.000224	0.0281	CbGeAlD
Cyclosporine—PPP3CA—tendon—bone cancer	0.000222	0.0279	CbGeAlD
Cyclosporine—PPIB—tendon—bone cancer	0.000221	0.0277	CbGeAlD
Cyclosporine—PPP3CA—bone marrow—bone cancer	0.000215	0.027	CbGeAlD
Cyclosporine—FKBP1A—connective tissue—bone cancer	0.000215	0.0269	CbGeAlD
Cyclosporine—PPP3CA—spinal cord—bone cancer	0.000215	0.0269	CbGeAlD
Cyclosporine—PPIB—bone marrow—bone cancer	0.000214	0.0268	CbGeAlD
Cyclosporine—PPIB—spinal cord—bone cancer	0.000213	0.0267	CbGeAlD
Cyclosporine—FKBP1A—tendon—bone cancer	0.000148	0.0185	CbGeAlD
Cyclosporine—FKBP1A—bone marrow—bone cancer	0.000143	0.0179	CbGeAlD
Cyclosporine—FKBP1A—spinal cord—bone cancer	0.000143	0.0178	CbGeAlD
Cyclosporine—ABCC10—tendon—bone cancer	0.000118	0.0148	CbGeAlD
Cyclosporine—Renal failure—Epirubicin—bone cancer	0.000118	0.000884	CcSEcCtD
Cyclosporine—Body temperature increased—Cisplatin—bone cancer	0.000118	0.000883	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Epirubicin—bone cancer	0.000118	0.000881	CcSEcCtD
Cyclosporine—Stomatitis—Epirubicin—bone cancer	0.000117	0.000876	CcSEcCtD
Cyclosporine—Jaundice—Epirubicin—bone cancer	0.000117	0.000876	CcSEcCtD
Cyclosporine—Urinary tract infection—Epirubicin—bone cancer	0.000117	0.000874	CcSEcCtD
Cyclosporine—Conjunctivitis—Epirubicin—bone cancer	0.000117	0.000874	CcSEcCtD
Cyclosporine—Dysuria—Doxorubicin—bone cancer	0.000117	0.000872	CcSEcCtD
Cyclosporine—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000116	0.000867	CcSEcCtD
Cyclosporine—Haemoglobin—Methotrexate—bone cancer	0.000116	0.000867	CcSEcCtD
Cyclosporine—Hepatitis—Methotrexate—bone cancer	0.000115	0.000862	CcSEcCtD
Cyclosporine—Haemorrhage—Methotrexate—bone cancer	0.000115	0.000862	CcSEcCtD
Cyclosporine—Pollakiuria—Doxorubicin—bone cancer	0.000115	0.000862	CcSEcCtD
Cyclosporine—ABCC10—bone marrow—bone cancer	0.000115	0.0144	CbGeAlD
Cyclosporine—Haematuria—Epirubicin—bone cancer	0.000115	0.000857	CcSEcCtD
Cyclosporine—Pharyngitis—Methotrexate—bone cancer	0.000114	0.000856	CcSEcCtD
Cyclosporine—ABCC10—spinal cord—bone cancer	0.000114	0.0143	CbGeAlD
Cyclosporine—Urinary tract disorder—Methotrexate—bone cancer	0.000114	0.000852	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Epirubicin—bone cancer	0.000114	0.00085	CcSEcCtD
Cyclosporine—Weight increased—Doxorubicin—bone cancer	0.000113	0.000849	CcSEcCtD
Cyclosporine—Epistaxis—Epirubicin—bone cancer	0.000113	0.000848	CcSEcCtD
Cyclosporine—Urethral disorder—Methotrexate—bone cancer	0.000113	0.000845	CcSEcCtD
Cyclosporine—Weight decreased—Doxorubicin—bone cancer	0.000113	0.000844	CcSEcCtD
Cyclosporine—Sinusitis—Epirubicin—bone cancer	0.000113	0.000843	CcSEcCtD
Cyclosporine—Hyperglycaemia—Doxorubicin—bone cancer	0.000112	0.000842	CcSEcCtD
Cyclosporine—Pneumonia—Doxorubicin—bone cancer	0.000112	0.000837	CcSEcCtD
Cyclosporine—Infestation NOS—Doxorubicin—bone cancer	0.000111	0.000832	CcSEcCtD
Cyclosporine—Infestation—Doxorubicin—bone cancer	0.000111	0.000832	CcSEcCtD
Cyclosporine—Visual impairment—Methotrexate—bone cancer	0.000111	0.000831	CcSEcCtD
Cyclosporine—Hypersensitivity—Cisplatin—bone cancer	0.00011	0.000823	CcSEcCtD
Cyclosporine—Renal failure—Doxorubicin—bone cancer	0.000109	0.000818	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Doxorubicin—bone cancer	0.000109	0.000815	CcSEcCtD
Cyclosporine—Haemoglobin—Epirubicin—bone cancer	0.000108	0.000811	CcSEcCtD
Cyclosporine—Jaundice—Doxorubicin—bone cancer	0.000108	0.000811	CcSEcCtD
Cyclosporine—Stomatitis—Doxorubicin—bone cancer	0.000108	0.000811	CcSEcCtD
Cyclosporine—Rhinitis—Epirubicin—bone cancer	0.000108	0.000809	CcSEcCtD
Cyclosporine—Conjunctivitis—Doxorubicin—bone cancer	0.000108	0.000809	CcSEcCtD
Cyclosporine—Urinary tract infection—Doxorubicin—bone cancer	0.000108	0.000809	CcSEcCtD
Cyclosporine—Haemorrhage—Epirubicin—bone cancer	0.000108	0.000807	CcSEcCtD
Cyclosporine—Hepatitis—Epirubicin—bone cancer	0.000108	0.000807	CcSEcCtD
Cyclosporine—Tinnitus—Methotrexate—bone cancer	0.000107	0.000804	CcSEcCtD
Cyclosporine—Hypoaesthesia—Epirubicin—bone cancer	0.000107	0.000803	CcSEcCtD
Cyclosporine—Asthenia—Cisplatin—bone cancer	0.000107	0.000801	CcSEcCtD
Cyclosporine—Pharyngitis—Epirubicin—bone cancer	0.000107	0.000801	CcSEcCtD
Cyclosporine—Urinary tract disorder—Epirubicin—bone cancer	0.000107	0.000797	CcSEcCtD
Cyclosporine—Haematuria—Doxorubicin—bone cancer	0.000106	0.000793	CcSEcCtD
Cyclosporine—Connective tissue disorder—Epirubicin—bone cancer	0.000106	0.000793	CcSEcCtD
Cyclosporine—Urethral disorder—Epirubicin—bone cancer	0.000106	0.000791	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Doxorubicin—bone cancer	0.000105	0.000787	CcSEcCtD
Cyclosporine—Epistaxis—Doxorubicin—bone cancer	0.000105	0.000785	CcSEcCtD
Cyclosporine—Angiopathy—Methotrexate—bone cancer	0.000105	0.000782	CcSEcCtD
Cyclosporine—Sinusitis—Doxorubicin—bone cancer	0.000104	0.00078	CcSEcCtD
Cyclosporine—Visual impairment—Epirubicin—bone cancer	0.000104	0.000778	CcSEcCtD
Cyclosporine—Mediastinal disorder—Methotrexate—bone cancer	0.000104	0.000777	CcSEcCtD
Cyclosporine—Chills—Methotrexate—bone cancer	0.000103	0.000774	CcSEcCtD
Cyclosporine—Diarrhoea—Cisplatin—bone cancer	0.000102	0.000764	CcSEcCtD
Cyclosporine—Alopecia—Methotrexate—bone cancer	0.000102	0.000762	CcSEcCtD
Cyclosporine—Mental disorder—Methotrexate—bone cancer	0.000101	0.000756	CcSEcCtD
Cyclosporine—Tinnitus—Epirubicin—bone cancer	0.000101	0.000752	CcSEcCtD
Cyclosporine—Malnutrition—Methotrexate—bone cancer	0.0001	0.000751	CcSEcCtD
Cyclosporine—Haemoglobin—Doxorubicin—bone cancer	0.0001	0.000751	CcSEcCtD
Cyclosporine—Flushing—Epirubicin—bone cancer	0.0001	0.000749	CcSEcCtD
Cyclosporine—Rhinitis—Doxorubicin—bone cancer	0.0001	0.000749	CcSEcCtD
Cyclosporine—Haemorrhage—Doxorubicin—bone cancer	9.98e-05	0.000747	CcSEcCtD
Cyclosporine—Hepatitis—Doxorubicin—bone cancer	9.98e-05	0.000747	CcSEcCtD
Cyclosporine—Hypoaesthesia—Doxorubicin—bone cancer	9.93e-05	0.000743	CcSEcCtD
Cyclosporine—Pharyngitis—Doxorubicin—bone cancer	9.91e-05	0.000741	CcSEcCtD
Cyclosporine—Urinary tract disorder—Doxorubicin—bone cancer	9.86e-05	0.000737	CcSEcCtD
Cyclosporine—SLCO1A2—spinal cord—bone cancer	9.84e-05	0.0123	CbGeAlD
Cyclosporine—Dysgeusia—Methotrexate—bone cancer	9.83e-05	0.000735	CcSEcCtD
Cyclosporine—Connective tissue disorder—Doxorubicin—bone cancer	9.81e-05	0.000734	CcSEcCtD
Cyclosporine—Angiopathy—Epirubicin—bone cancer	9.79e-05	0.000732	CcSEcCtD
Cyclosporine—Urethral disorder—Doxorubicin—bone cancer	9.79e-05	0.000732	CcSEcCtD
Cyclosporine—Mediastinal disorder—Epirubicin—bone cancer	9.72e-05	0.000727	CcSEcCtD
Cyclosporine—Chills—Epirubicin—bone cancer	9.68e-05	0.000724	CcSEcCtD
Cyclosporine—Arrhythmia—Epirubicin—bone cancer	9.64e-05	0.000721	CcSEcCtD
Cyclosporine—Visual impairment—Doxorubicin—bone cancer	9.62e-05	0.00072	CcSEcCtD
Cyclosporine—Alopecia—Epirubicin—bone cancer	9.53e-05	0.000713	CcSEcCtD
Cyclosporine—ABCC2—tendon—bone cancer	9.51e-05	0.0119	CbGeAlD
Cyclosporine—Vomiting—Cisplatin—bone cancer	9.49e-05	0.00071	CcSEcCtD
Cyclosporine—Vision blurred—Methotrexate—bone cancer	9.46e-05	0.000707	CcSEcCtD
Cyclosporine—Mental disorder—Epirubicin—bone cancer	9.45e-05	0.000707	CcSEcCtD
Cyclosporine—Rash—Cisplatin—bone cancer	9.41e-05	0.000704	CcSEcCtD
Cyclosporine—Dermatitis—Cisplatin—bone cancer	9.4e-05	0.000703	CcSEcCtD
Cyclosporine—Malnutrition—Epirubicin—bone cancer	9.39e-05	0.000703	CcSEcCtD
Cyclosporine—Ill-defined disorder—Methotrexate—bone cancer	9.31e-05	0.000697	CcSEcCtD
Cyclosporine—Tinnitus—Doxorubicin—bone cancer	9.31e-05	0.000696	CcSEcCtD
Cyclosporine—Anaemia—Methotrexate—bone cancer	9.28e-05	0.000694	CcSEcCtD
Cyclosporine—Flushing—Doxorubicin—bone cancer	9.26e-05	0.000693	CcSEcCtD
Cyclosporine—Flatulence—Epirubicin—bone cancer	9.25e-05	0.000692	CcSEcCtD
Cyclosporine—Tension—Epirubicin—bone cancer	9.22e-05	0.000689	CcSEcCtD
Cyclosporine—Dysgeusia—Epirubicin—bone cancer	9.2e-05	0.000688	CcSEcCtD
Cyclosporine—Nervousness—Epirubicin—bone cancer	9.12e-05	0.000682	CcSEcCtD
Cyclosporine—Angiopathy—Doxorubicin—bone cancer	9.06e-05	0.000677	CcSEcCtD
Cyclosporine—Malaise—Methotrexate—bone cancer	9.05e-05	0.000677	CcSEcCtD
Cyclosporine—Muscle spasms—Epirubicin—bone cancer	9.03e-05	0.000675	CcSEcCtD
Cyclosporine—Vertigo—Methotrexate—bone cancer	9.02e-05	0.000674	CcSEcCtD
Cyclosporine—Mediastinal disorder—Doxorubicin—bone cancer	9e-05	0.000673	CcSEcCtD
Cyclosporine—Leukopenia—Methotrexate—bone cancer	8.98e-05	0.000672	CcSEcCtD
Cyclosporine—Chills—Doxorubicin—bone cancer	8.96e-05	0.00067	CcSEcCtD
Cyclosporine—Arrhythmia—Doxorubicin—bone cancer	8.92e-05	0.000667	CcSEcCtD
Cyclosporine—Nausea—Cisplatin—bone cancer	8.87e-05	0.000663	CcSEcCtD
Cyclosporine—Vision blurred—Epirubicin—bone cancer	8.85e-05	0.000662	CcSEcCtD
Cyclosporine—Alopecia—Doxorubicin—bone cancer	8.82e-05	0.00066	CcSEcCtD
Cyclosporine—Cough—Methotrexate—bone cancer	8.76e-05	0.000655	CcSEcCtD
Cyclosporine—Mental disorder—Doxorubicin—bone cancer	8.75e-05	0.000654	CcSEcCtD
Cyclosporine—Ill-defined disorder—Epirubicin—bone cancer	8.71e-05	0.000652	CcSEcCtD
Cyclosporine—Convulsion—Methotrexate—bone cancer	8.69e-05	0.00065	CcSEcCtD
Cyclosporine—Malnutrition—Doxorubicin—bone cancer	8.69e-05	0.00065	CcSEcCtD
Cyclosporine—Anaemia—Epirubicin—bone cancer	8.68e-05	0.000649	CcSEcCtD
Cyclosporine—Agitation—Epirubicin—bone cancer	8.63e-05	0.000646	CcSEcCtD
Cyclosporine—Flatulence—Doxorubicin—bone cancer	8.56e-05	0.000641	CcSEcCtD
Cyclosporine—Arthralgia—Methotrexate—bone cancer	8.54e-05	0.000639	CcSEcCtD
Cyclosporine—Myalgia—Methotrexate—bone cancer	8.54e-05	0.000639	CcSEcCtD
Cyclosporine—Chest pain—Methotrexate—bone cancer	8.54e-05	0.000639	CcSEcCtD
Cyclosporine—Tension—Doxorubicin—bone cancer	8.53e-05	0.000638	CcSEcCtD
Cyclosporine—Dysgeusia—Doxorubicin—bone cancer	8.51e-05	0.000637	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	8.48e-05	0.000635	CcSEcCtD
Cyclosporine—Malaise—Epirubicin—bone cancer	8.47e-05	0.000634	CcSEcCtD
Cyclosporine—Discomfort—Methotrexate—bone cancer	8.44e-05	0.000631	CcSEcCtD
Cyclosporine—Nervousness—Doxorubicin—bone cancer	8.44e-05	0.000631	CcSEcCtD
Cyclosporine—Vertigo—Epirubicin—bone cancer	8.44e-05	0.000631	CcSEcCtD
Cyclosporine—Leukopenia—Epirubicin—bone cancer	8.41e-05	0.000629	CcSEcCtD
Cyclosporine—ABCC1—tendon—bone cancer	8.37e-05	0.0105	CbGeAlD
Cyclosporine—Muscle spasms—Doxorubicin—bone cancer	8.35e-05	0.000625	CcSEcCtD
Cyclosporine—Confusional state—Methotrexate—bone cancer	8.26e-05	0.000618	CcSEcCtD
Cyclosporine—Cough—Epirubicin—bone cancer	8.2e-05	0.000613	CcSEcCtD
Cyclosporine—Anaphylactic shock—Methotrexate—bone cancer	8.19e-05	0.000613	CcSEcCtD
Cyclosporine—Vision blurred—Doxorubicin—bone cancer	8.19e-05	0.000613	CcSEcCtD
Cyclosporine—Convulsion—Epirubicin—bone cancer	8.14e-05	0.000609	CcSEcCtD
Cyclosporine—Infection—Methotrexate—bone cancer	8.14e-05	0.000609	CcSEcCtD
Cyclosporine—Hypertension—Epirubicin—bone cancer	8.11e-05	0.000607	CcSEcCtD
Cyclosporine—Ill-defined disorder—Doxorubicin—bone cancer	8.06e-05	0.000603	CcSEcCtD
Cyclosporine—Nervous system disorder—Methotrexate—bone cancer	8.03e-05	0.000601	CcSEcCtD
Cyclosporine—Anaemia—Doxorubicin—bone cancer	8.03e-05	0.000601	CcSEcCtD
Cyclosporine—Thrombocytopenia—Methotrexate—bone cancer	8.02e-05	0.0006	CcSEcCtD
Cyclosporine—Myalgia—Epirubicin—bone cancer	8e-05	0.000598	CcSEcCtD
Cyclosporine—Chest pain—Epirubicin—bone cancer	8e-05	0.000598	CcSEcCtD
Cyclosporine—Arthralgia—Epirubicin—bone cancer	8e-05	0.000598	CcSEcCtD
Cyclosporine—Agitation—Doxorubicin—bone cancer	7.99e-05	0.000597	CcSEcCtD
Cyclosporine—Anxiety—Epirubicin—bone cancer	7.97e-05	0.000596	CcSEcCtD
Cyclosporine—Skin disorder—Methotrexate—bone cancer	7.96e-05	0.000595	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	7.94e-05	0.000594	CcSEcCtD
Cyclosporine—Hyperhidrosis—Methotrexate—bone cancer	7.92e-05	0.000592	CcSEcCtD
Cyclosporine—Discomfort—Epirubicin—bone cancer	7.9e-05	0.000591	CcSEcCtD
Cyclosporine—Malaise—Doxorubicin—bone cancer	7.84e-05	0.000586	CcSEcCtD
Cyclosporine—Dry mouth—Epirubicin—bone cancer	7.82e-05	0.000585	CcSEcCtD
Cyclosporine—Vertigo—Doxorubicin—bone cancer	7.81e-05	0.000584	CcSEcCtD
Cyclosporine—Anorexia—Methotrexate—bone cancer	7.81e-05	0.000584	CcSEcCtD
Cyclosporine—Leukopenia—Doxorubicin—bone cancer	7.78e-05	0.000582	CcSEcCtD
Cyclosporine—Confusional state—Epirubicin—bone cancer	7.73e-05	0.000578	CcSEcCtD
Cyclosporine—Oedema—Epirubicin—bone cancer	7.66e-05	0.000573	CcSEcCtD
Cyclosporine—Anaphylactic shock—Epirubicin—bone cancer	7.66e-05	0.000573	CcSEcCtD
Cyclosporine—Infection—Epirubicin—bone cancer	7.61e-05	0.00057	CcSEcCtD
Cyclosporine—Cough—Doxorubicin—bone cancer	7.58e-05	0.000567	CcSEcCtD
Cyclosporine—Convulsion—Doxorubicin—bone cancer	7.53e-05	0.000563	CcSEcCtD
Cyclosporine—Nervous system disorder—Epirubicin—bone cancer	7.52e-05	0.000562	CcSEcCtD
Cyclosporine—Thrombocytopenia—Epirubicin—bone cancer	7.5e-05	0.000561	CcSEcCtD
Cyclosporine—Hypertension—Doxorubicin—bone cancer	7.5e-05	0.000561	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Methotrexate—bone cancer	7.46e-05	0.000558	CcSEcCtD
Cyclosporine—Skin disorder—Epirubicin—bone cancer	7.44e-05	0.000557	CcSEcCtD
Cyclosporine—Hyperhidrosis—Epirubicin—bone cancer	7.41e-05	0.000554	CcSEcCtD
Cyclosporine—Insomnia—Methotrexate—bone cancer	7.41e-05	0.000554	CcSEcCtD
Cyclosporine—Arthralgia—Doxorubicin—bone cancer	7.4e-05	0.000553	CcSEcCtD
Cyclosporine—Chest pain—Doxorubicin—bone cancer	7.4e-05	0.000553	CcSEcCtD
Cyclosporine—Myalgia—Doxorubicin—bone cancer	7.4e-05	0.000553	CcSEcCtD
Cyclosporine—Anxiety—Doxorubicin—bone cancer	7.37e-05	0.000551	CcSEcCtD
Cyclosporine—Paraesthesia—Methotrexate—bone cancer	7.35e-05	0.00055	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	7.35e-05	0.00055	CcSEcCtD
Cyclosporine—Discomfort—Doxorubicin—bone cancer	7.31e-05	0.000547	CcSEcCtD
Cyclosporine—Anorexia—Epirubicin—bone cancer	7.31e-05	0.000547	CcSEcCtD
Cyclosporine—Dyspnoea—Methotrexate—bone cancer	7.3e-05	0.000546	CcSEcCtD
Cyclosporine—Somnolence—Methotrexate—bone cancer	7.28e-05	0.000545	CcSEcCtD
Cyclosporine—Dry mouth—Doxorubicin—bone cancer	7.24e-05	0.000541	CcSEcCtD
Cyclosporine—Dyspepsia—Methotrexate—bone cancer	7.21e-05	0.000539	CcSEcCtD
Cyclosporine—Confusional state—Doxorubicin—bone cancer	7.15e-05	0.000535	CcSEcCtD
Cyclosporine—Decreased appetite—Methotrexate—bone cancer	7.12e-05	0.000533	CcSEcCtD
Cyclosporine—Anaphylactic shock—Doxorubicin—bone cancer	7.09e-05	0.000531	CcSEcCtD
Cyclosporine—Oedema—Doxorubicin—bone cancer	7.09e-05	0.000531	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Methotrexate—bone cancer	7.07e-05	0.000529	CcSEcCtD
Cyclosporine—Fatigue—Methotrexate—bone cancer	7.06e-05	0.000528	CcSEcCtD
Cyclosporine—Infection—Doxorubicin—bone cancer	7.05e-05	0.000527	CcSEcCtD
Cyclosporine—Pain—Methotrexate—bone cancer	7e-05	0.000524	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Epirubicin—bone cancer	6.98e-05	0.000522	CcSEcCtD
Cyclosporine—Nervous system disorder—Doxorubicin—bone cancer	6.95e-05	0.00052	CcSEcCtD
Cyclosporine—Thrombocytopenia—Doxorubicin—bone cancer	6.94e-05	0.000519	CcSEcCtD
Cyclosporine—Insomnia—Epirubicin—bone cancer	6.93e-05	0.000519	CcSEcCtD
Cyclosporine—Skin disorder—Doxorubicin—bone cancer	6.89e-05	0.000515	CcSEcCtD
Cyclosporine—Paraesthesia—Epirubicin—bone cancer	6.88e-05	0.000515	CcSEcCtD
Cyclosporine—Hyperhidrosis—Doxorubicin—bone cancer	6.86e-05	0.000513	CcSEcCtD
Cyclosporine—Dyspnoea—Epirubicin—bone cancer	6.83e-05	0.000511	CcSEcCtD
Cyclosporine—Somnolence—Epirubicin—bone cancer	6.81e-05	0.00051	CcSEcCtD
Cyclosporine—Anorexia—Doxorubicin—bone cancer	6.76e-05	0.000506	CcSEcCtD
Cyclosporine—Feeling abnormal—Methotrexate—bone cancer	6.75e-05	0.000505	CcSEcCtD
Cyclosporine—Dyspepsia—Epirubicin—bone cancer	6.75e-05	0.000505	CcSEcCtD
Cyclosporine—ABCG2—bone marrow—bone cancer	6.72e-05	0.00841	CbGeAlD
Cyclosporine—Gastrointestinal pain—Methotrexate—bone cancer	6.7e-05	0.000501	CcSEcCtD
Cyclosporine—ABCG2—spinal cord—bone cancer	6.69e-05	0.00837	CbGeAlD
Cyclosporine—Decreased appetite—Epirubicin—bone cancer	6.66e-05	0.000498	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Epirubicin—bone cancer	6.62e-05	0.000495	CcSEcCtD
Cyclosporine—Fatigue—Epirubicin—bone cancer	6.61e-05	0.000494	CcSEcCtD
Cyclosporine—Pain—Epirubicin—bone cancer	6.55e-05	0.00049	CcSEcCtD
Cyclosporine—Constipation—Epirubicin—bone cancer	6.55e-05	0.00049	CcSEcCtD
Cyclosporine—Urticaria—Methotrexate—bone cancer	6.51e-05	0.000487	CcSEcCtD
Cyclosporine—Body temperature increased—Methotrexate—bone cancer	6.47e-05	0.000484	CcSEcCtD
Cyclosporine—Abdominal pain—Methotrexate—bone cancer	6.47e-05	0.000484	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Doxorubicin—bone cancer	6.46e-05	0.000483	CcSEcCtD
Cyclosporine—Insomnia—Doxorubicin—bone cancer	6.41e-05	0.00048	CcSEcCtD
Cyclosporine—Paraesthesia—Doxorubicin—bone cancer	6.37e-05	0.000476	CcSEcCtD
Cyclosporine—Dyspnoea—Doxorubicin—bone cancer	6.32e-05	0.000473	CcSEcCtD
Cyclosporine—Feeling abnormal—Epirubicin—bone cancer	6.32e-05	0.000472	CcSEcCtD
Cyclosporine—Somnolence—Doxorubicin—bone cancer	6.3e-05	0.000472	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Epirubicin—bone cancer	6.27e-05	0.000469	CcSEcCtD
Cyclosporine—Dyspepsia—Doxorubicin—bone cancer	6.24e-05	0.000467	CcSEcCtD
Cyclosporine—Decreased appetite—Doxorubicin—bone cancer	6.16e-05	0.000461	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Doxorubicin—bone cancer	6.12e-05	0.000458	CcSEcCtD
Cyclosporine—Fatigue—Doxorubicin—bone cancer	6.11e-05	0.000457	CcSEcCtD
Cyclosporine—Urticaria—Epirubicin—bone cancer	6.09e-05	0.000455	CcSEcCtD
Cyclosporine—Pain—Doxorubicin—bone cancer	6.06e-05	0.000454	CcSEcCtD
Cyclosporine—Constipation—Doxorubicin—bone cancer	6.06e-05	0.000454	CcSEcCtD
Cyclosporine—Body temperature increased—Epirubicin—bone cancer	6.06e-05	0.000453	CcSEcCtD
Cyclosporine—Abdominal pain—Epirubicin—bone cancer	6.06e-05	0.000453	CcSEcCtD
Cyclosporine—Hypersensitivity—Methotrexate—bone cancer	6.03e-05	0.000451	CcSEcCtD
Cyclosporine—Asthenia—Methotrexate—bone cancer	5.88e-05	0.00044	CcSEcCtD
Cyclosporine—Feeling abnormal—Doxorubicin—bone cancer	5.84e-05	0.000437	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Doxorubicin—bone cancer	5.8e-05	0.000434	CcSEcCtD
Cyclosporine—Pruritus—Methotrexate—bone cancer	5.79e-05	0.000433	CcSEcCtD
Cyclosporine—ABCG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.77e-05	0.000624	CbGpPWpGaD
Cyclosporine—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.73e-05	0.00062	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—NDUFA12—bone cancer	5.7e-05	0.000616	CbGpPWpGaD
Cyclosporine—ABCC1—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.66e-05	0.000612	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—NT5C3A—bone cancer	5.65e-05	0.000612	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—GNA11—bone cancer	5.65e-05	0.000612	CbGpPWpGaD
Cyclosporine—Hypersensitivity—Epirubicin—bone cancer	5.65e-05	0.000422	CcSEcCtD
Cyclosporine—Urticaria—Doxorubicin—bone cancer	5.63e-05	0.000421	CcSEcCtD
Cyclosporine—PPP3CA—Disease—ENO2—bone cancer	5.63e-05	0.000609	CbGpPWpGaD
Cyclosporine—Abdominal pain—Doxorubicin—bone cancer	5.61e-05	0.000419	CcSEcCtD
Cyclosporine—Body temperature increased—Doxorubicin—bone cancer	5.61e-05	0.000419	CcSEcCtD
Cyclosporine—Diarrhoea—Methotrexate—bone cancer	5.6e-05	0.000419	CcSEcCtD
Cyclosporine—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	5.56e-05	0.000601	CbGpPWpGaD
Cyclosporine—Asthenia—Epirubicin—bone cancer	5.5e-05	0.000411	CcSEcCtD
Cyclosporine—Pruritus—Epirubicin—bone cancer	5.42e-05	0.000406	CcSEcCtD
Cyclosporine—ABCC3—Metabolism—NT5C3A—bone cancer	5.42e-05	0.000586	CbGpPWpGaD
Cyclosporine—Dizziness—Methotrexate—bone cancer	5.42e-05	0.000405	CcSEcCtD
Cyclosporine—CYP3A5—Biological oxidations—CYP3A4—bone cancer	5.39e-05	0.000583	CbGpPWpGaD
Cyclosporine—SLCO1B1—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.38e-05	0.000582	CbGpPWpGaD
Cyclosporine—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	5.32e-05	0.000575	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	5.31e-05	0.000574	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—GRM1—bone cancer	5.3e-05	0.000574	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—IL3—bone cancer	5.24e-05	0.000568	CbGpPWpGaD
Cyclosporine—Diarrhoea—Epirubicin—bone cancer	5.24e-05	0.000392	CcSEcCtD
Cyclosporine—Hypersensitivity—Doxorubicin—bone cancer	5.23e-05	0.000391	CcSEcCtD
Cyclosporine—PPP3CA—Disease—DHFR—bone cancer	5.22e-05	0.000565	CbGpPWpGaD
Cyclosporine—Vomiting—Methotrexate—bone cancer	5.21e-05	0.00039	CcSEcCtD
Cyclosporine—Rash—Methotrexate—bone cancer	5.16e-05	0.000386	CcSEcCtD
Cyclosporine—Dermatitis—Methotrexate—bone cancer	5.16e-05	0.000386	CcSEcCtD
Cyclosporine—Headache—Methotrexate—bone cancer	5.13e-05	0.000384	CcSEcCtD
Cyclosporine—ABCC1—Metabolism—NDUFA12—bone cancer	5.12e-05	0.000555	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—CYP3A4—bone cancer	5.12e-05	0.000555	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.1e-05	0.000552	CbGpPWpGaD
Cyclosporine—Asthenia—Doxorubicin—bone cancer	5.09e-05	0.000381	CcSEcCtD
Cyclosporine—Dizziness—Epirubicin—bone cancer	5.07e-05	0.000379	CcSEcCtD
Cyclosporine—Pruritus—Doxorubicin—bone cancer	5.02e-05	0.000375	CcSEcCtD
Cyclosporine—ABCG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.98e-05	0.000539	CbGpPWpGaD
Cyclosporine—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	4.96e-05	0.000537	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—ATF1—bone cancer	4.91e-05	0.000532	CbGpPWpGaD
Cyclosporine—Vomiting—Epirubicin—bone cancer	4.87e-05	0.000365	CcSEcCtD
Cyclosporine—SLCO1B1—Metabolism—NDUFA12—bone cancer	4.87e-05	0.000527	CbGpPWpGaD
Cyclosporine—Nausea—Methotrexate—bone cancer	4.86e-05	0.000364	CcSEcCtD
Cyclosporine—Diarrhoea—Doxorubicin—bone cancer	4.85e-05	0.000363	CcSEcCtD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	4.85e-05	0.000525	CbGpPWpGaD
Cyclosporine—Rash—Epirubicin—bone cancer	4.83e-05	0.000362	CcSEcCtD
Cyclosporine—Dermatitis—Epirubicin—bone cancer	4.83e-05	0.000361	CcSEcCtD
Cyclosporine—Headache—Epirubicin—bone cancer	4.8e-05	0.000359	CcSEcCtD
Cyclosporine—PPP3CA—Innate Immune System—KIT—bone cancer	4.8e-05	0.00052	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IL3—bone cancer	4.79e-05	0.000519	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—GRM4—bone cancer	4.74e-05	0.000513	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—RGS1—bone cancer	4.74e-05	0.000513	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—NT5C3A—bone cancer	4.72e-05	0.000511	CbGpPWpGaD
Cyclosporine—Dizziness—Doxorubicin—bone cancer	4.69e-05	0.000351	CcSEcCtD
Cyclosporine—CYP2C8—Biological oxidations—CYP3A4—bone cancer	4.67e-05	0.000505	CbGpPWpGaD
Cyclosporine—CYP3A5—Biological oxidations—GSTP1—bone cancer	4.61e-05	0.000499	CbGpPWpGaD
Cyclosporine—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	4.6e-05	0.000498	CbGpPWpGaD
Cyclosporine—PPIA—Disease—TGFBR2—bone cancer	4.55e-05	0.000493	CbGpPWpGaD
Cyclosporine—Nausea—Epirubicin—bone cancer	4.55e-05	0.000341	CcSEcCtD
Cyclosporine—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	4.55e-05	0.000492	CbGpPWpGaD
Cyclosporine—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	4.52e-05	0.00049	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	4.51e-05	0.000488	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—NDUFA12—bone cancer	4.51e-05	0.000488	CbGpPWpGaD
Cyclosporine—Vomiting—Doxorubicin—bone cancer	4.51e-05	0.000337	CcSEcCtD
Cyclosporine—Rash—Doxorubicin—bone cancer	4.47e-05	0.000334	CcSEcCtD
Cyclosporine—CYP3A7—Metabolism—NDUFA12—bone cancer	4.47e-05	0.000484	CbGpPWpGaD
Cyclosporine—Dermatitis—Doxorubicin—bone cancer	4.47e-05	0.000334	CcSEcCtD
Cyclosporine—Headache—Doxorubicin—bone cancer	4.44e-05	0.000332	CcSEcCtD
Cyclosporine—SLC10A2—Metabolism—GSTP1—bone cancer	4.38e-05	0.000474	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—ENO2—bone cancer	4.36e-05	0.000472	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—NT5C3A—bone cancer	4.25e-05	0.00046	CbGpPWpGaD
Cyclosporine—Nausea—Doxorubicin—bone cancer	4.21e-05	0.000315	CcSEcCtD
Cyclosporine—SLC10A1—Metabolism—ENO2—bone cancer	4.2e-05	0.000455	CbGpPWpGaD
Cyclosporine—CYP2C19—Biological oxidations—CYP3A4—bone cancer	4.17e-05	0.000451	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—GRM1—bone cancer	4.11e-05	0.000445	CbGpPWpGaD
Cyclosporine—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	4.11e-05	0.000445	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	4.11e-05	0.000444	CbGpPWpGaD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	4.07e-05	0.000441	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—DHFR—bone cancer	4.05e-05	0.000438	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—NT5C3A—bone cancer	4.04e-05	0.000437	CbGpPWpGaD
Cyclosporine—CYP2C8—Biological oxidations—GSTP1—bone cancer	3.99e-05	0.000432	CbGpPWpGaD
Cyclosporine—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	3.94e-05	0.000426	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—DHFR—bone cancer	3.9e-05	0.000422	CbGpPWpGaD
Cyclosporine—CYP2D6—Biological oxidations—CYP3A4—bone cancer	3.83e-05	0.000415	CbGpPWpGaD
Cyclosporine—CYP2C9—Biological oxidations—CYP3A4—bone cancer	3.8e-05	0.000411	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—TGFBR2—bone cancer	3.78e-05	0.000409	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—MDM2—bone cancer	3.78e-05	0.000409	CbGpPWpGaD
Cyclosporine—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	3.78e-05	0.000409	CbGpPWpGaD
Cyclosporine—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	3.75e-05	0.000406	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	3.74e-05	0.000405	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—NT5C3A—bone cancer	3.74e-05	0.000404	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—SMO—bone cancer	3.74e-05	0.000404	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—NT5C3A—bone cancer	3.7e-05	0.000401	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	3.69e-05	0.000399	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—GNA11—bone cancer	3.64e-05	0.000394	CbGpPWpGaD
Cyclosporine—CYP2C19—Biological oxidations—GSTP1—bone cancer	3.56e-05	0.000386	CbGpPWpGaD
Cyclosporine—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	3.52e-05	0.00038	CbGpPWpGaD
Cyclosporine—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	3.5e-05	0.000378	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—GNA11—bone cancer	3.42e-05	0.00037	CbGpPWpGaD
Cyclosporine—ABCB1—bone marrow—bone cancer	3.31e-05	0.00415	CbGeAlD
Cyclosporine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	3.31e-05	0.000358	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—CYP3A4—bone cancer	3.3e-05	0.000357	CbGpPWpGaD
Cyclosporine—ABCB1—spinal cord—bone cancer	3.3e-05	0.00413	CbGeAlD
Cyclosporine—PPP3CA—Innate Immune System—JUN—bone cancer	3.29e-05	0.000356	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.29e-05	0.000356	CbGpPWpGaD
Cyclosporine—CYP2D6—Biological oxidations—GSTP1—bone cancer	3.28e-05	0.000355	CbGpPWpGaD
Cyclosporine—CYP2C9—Biological oxidations—GSTP1—bone cancer	3.25e-05	0.000352	CbGpPWpGaD
Cyclosporine—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	3.23e-05	0.00035	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—NDUFA12—bone cancer	3.23e-05	0.00035	CbGpPWpGaD
Cyclosporine—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	3.21e-05	0.000347	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—ATF1—bone cancer	3.18e-05	0.000344	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	3.13e-05	0.000338	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.12e-05	0.000337	CbGpPWpGaD
Cyclosporine—PPIA—Disease—KIT—bone cancer	3.11e-05	0.000336	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—IL3—bone cancer	3.1e-05	0.000335	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—TGFBR2—bone cancer	2.93e-05	0.000317	CbGpPWpGaD
Cyclosporine—PPIA—Disease—BRAF—bone cancer	2.92e-05	0.000316	CbGpPWpGaD
Cyclosporine—PPIA—Hemostasis—TP53—bone cancer	2.9e-05	0.000314	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—SMO—bone cancer	2.9e-05	0.000314	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—GSTP1—bone cancer	2.82e-05	0.000306	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—NDUFA12—bone cancer	2.8e-05	0.000303	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—KIT—bone cancer	2.8e-05	0.000303	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.69e-05	0.000291	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—NT5C3A—bone cancer	2.68e-05	0.00029	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TGFBR2—bone cancer	2.65e-05	0.000287	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—GNA11—bone cancer	2.65e-05	0.000287	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—EGFR—bone cancer	2.58e-05	0.00028	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—KIT—bone cancer	2.58e-05	0.000279	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—NDUFA12—bone cancer	2.5e-05	0.00027	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—IGF1R—bone cancer	2.49e-05	0.00027	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—ENO2—bone cancer	2.48e-05	0.000268	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—ATF1—bone cancer	2.46e-05	0.000267	CbGpPWpGaD
Cyclosporine—PPIA—Disease—MDM2—bone cancer	2.45e-05	0.000265	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—NDUFA12—bone cancer	2.44e-05	0.000264	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—BRAF—bone cancer	2.43e-05	0.000263	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL3—bone cancer	2.4e-05	0.00026	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—ENO2—bone cancer	2.37e-05	0.000257	CbGpPWpGaD
Cyclosporine—PPIA—Disease—PTGS2—bone cancer	2.36e-05	0.000255	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	2.32e-05	0.000251	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—NT5C3A—bone cancer	2.32e-05	0.000251	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—NDUFA12—bone cancer	2.3e-05	0.000249	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—DHFR—bone cancer	2.3e-05	0.000249	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—NDUFA12—bone cancer	2.28e-05	0.000246	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—PTGS2—bone cancer	2.27e-05	0.000246	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—ENO2—bone cancer	2.22e-05	0.00024	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—MDM2—bone cancer	2.2e-05	0.000238	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—DHFR—bone cancer	2.2e-05	0.000238	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—GNA11—bone cancer	2.15e-05	0.000232	CbGpPWpGaD
Cyclosporine—CYP3A4—Biological oxidations—GSTP1—bone cancer	2.14e-05	0.000232	CbGpPWpGaD
Cyclosporine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	2.11e-05	0.000229	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—NT5C3A—bone cancer	2.07e-05	0.000224	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—ENO2—bone cancer	2.07e-05	0.000224	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—DHFR—bone cancer	2.06e-05	0.000223	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—GNA11—bone cancer	2.06e-05	0.000223	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TGFBR2—bone cancer	2.05e-05	0.000222	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—MDM2—bone cancer	2.03e-05	0.00022	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—NT5C3A—bone cancer	2.02e-05	0.000219	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—KIT—bone cancer	2e-05	0.000217	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—PTGS2—bone cancer	1.96e-05	0.000212	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—CYP3A4—bone cancer	1.95e-05	0.000211	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.94e-05	0.00021	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IGF1R—bone cancer	1.93e-05	0.000209	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—DHFR—bone cancer	1.92e-05	0.000208	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—JUN—bone cancer	1.91e-05	0.000207	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—NT5C3A—bone cancer	1.9e-05	0.000206	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—NT5C3A—bone cancer	1.89e-05	0.000204	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—BRAF—bone cancer	1.88e-05	0.000204	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—CYP3A4—bone cancer	1.87e-05	0.000202	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—ENO2—bone cancer	1.86e-05	0.000201	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.86e-05	0.000201	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—KIT—bone cancer	1.81e-05	0.000196	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—GNA11—bone cancer	1.79e-05	0.000194	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—ENO2—bone cancer	1.77e-05	0.000191	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—DHFR—bone cancer	1.73e-05	0.000187	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	1.72e-05	0.000186	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—BRAF—bone cancer	1.7e-05	0.000184	CbGpPWpGaD
Cyclosporine—PPIA—Disease—EGFR—bone cancer	1.67e-05	0.000181	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—GSTP1—bone cancer	1.66e-05	0.00018	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	1.66e-05	0.000179	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—EGFR—bone cancer	1.65e-05	0.000178	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—DHFR—bone cancer	1.64e-05	0.000177	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—ENO2—bone cancer	1.64e-05	0.000177	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—CYP3A4—bone cancer	1.62e-05	0.000176	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—ENO2—bone cancer	1.62e-05	0.000176	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.62e-05	0.000175	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—GNA11—bone cancer	1.61e-05	0.000175	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—GSTP1—bone cancer	1.6e-05	0.000173	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—MDM2—bone cancer	1.58e-05	0.000171	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—GNA11—bone cancer	1.53e-05	0.000166	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—PTGS2—bone cancer	1.52e-05	0.000164	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—DHFR—bone cancer	1.52e-05	0.000164	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—EGFR—bone cancer	1.51e-05	0.000163	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—DHFR—bone cancer	1.51e-05	0.000163	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NDUFA12—bone cancer	1.5e-05	0.000163	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.49e-05	0.000162	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—TGFBR2—bone cancer	1.49e-05	0.000162	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—PTGS2—bone cancer	1.46e-05	0.000158	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—CYP3A4—bone cancer	1.46e-05	0.000158	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.45e-05	0.000157	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MDM2—bone cancer	1.42e-05	0.000154	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—GNA11—bone cancer	1.42e-05	0.000154	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—GNA11—bone cancer	1.41e-05	0.000152	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—KIT—bone cancer	1.4e-05	0.000152	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—GSTP1—bone cancer	1.39e-05	0.00015	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—EGFR—bone cancer	1.39e-05	0.00015	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—CYP3A4—bone cancer	1.39e-05	0.00015	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.38e-05	0.00015	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—BRAF—bone cancer	1.32e-05	0.000143	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—CYP3A4—bone cancer	1.29e-05	0.000139	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—CYP3A4—bone cancer	1.28e-05	0.000138	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—GSTP1—bone cancer	1.25e-05	0.000135	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NT5C3A—bone cancer	1.24e-05	0.000135	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—JUN—bone cancer	1.24e-05	0.000134	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MMP9—bone cancer	1.2e-05	0.00013	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—GSTP1—bone cancer	1.19e-05	0.000129	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.17e-05	0.000127	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ENO2—bone cancer	1.17e-05	0.000127	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MDM2—bone cancer	1.1e-05	0.000119	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—GSTP1—bone cancer	1.1e-05	0.000119	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—GSTP1—bone cancer	1.09e-05	0.000118	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—DHFR—bone cancer	1.09e-05	0.000118	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—EGFR—bone cancer	1.08e-05	0.000117	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—KIT—bone cancer	1.02e-05	0.00011	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GNA11—bone cancer	1.02e-05	0.00011	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ENO2—bone cancer	1.02e-05	0.00011	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	9.86e-06	0.000107	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—EGFR—bone cancer	9.73e-06	0.000105	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—JUN—bone cancer	9.6e-06	0.000104	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—BRAF—bone cancer	9.58e-06	0.000104	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—DHFR—bone cancer	9.42e-06	0.000102	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MMP9—bone cancer	9.34e-06	0.000101	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CYP3A4—bone cancer	9.22e-06	9.98e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ENO2—bone cancer	9.07e-06	9.81e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ENO2—bone cancer	8.85e-06	9.58e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GNA11—bone cancer	8.81e-06	9.53e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PTGS2—bone cancer	8.62e-06	9.33e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—DHFR—bone cancer	8.41e-06	9.1e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ENO2—bone cancer	8.34e-06	9.02e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PTGS2—bone cancer	8.27e-06	8.95e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ENO2—bone cancer	8.27e-06	8.95e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—DHFR—bone cancer	8.21e-06	8.88e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TP53—bone cancer	8.17e-06	8.84e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MDM2—bone cancer	8.02e-06	8.68e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CYP3A4—bone cancer	7.98e-06	8.64e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.94e-06	8.6e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GSTP1—bone cancer	7.88e-06	8.53e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GNA11—bone cancer	7.86e-06	8.51e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—DHFR—bone cancer	7.74e-06	8.37e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PTGS2—bone cancer	7.74e-06	8.37e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GNA11—bone cancer	7.67e-06	8.3e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—DHFR—bone cancer	7.67e-06	8.3e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—EGFR—bone cancer	7.55e-06	8.17e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GNA11—bone cancer	7.23e-06	7.82e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PTGS2—bone cancer	7.2e-06	7.79e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GNA11—bone cancer	7.17e-06	7.76e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CYP3A4—bone cancer	7.13e-06	7.71e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.09e-06	7.67e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CYP3A4—bone cancer	6.96e-06	7.53e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GSTP1—bone cancer	6.83e-06	7.39e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYP3A4—bone cancer	6.55e-06	7.09e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYP3A4—bone cancer	6.5e-06	7.03e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PTGS2—bone cancer	6.48e-06	7.01e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.47e-06	7e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TP53—bone cancer	6.34e-06	6.86e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PTGS2—bone cancer	6.16e-06	6.66e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GSTP1—bone cancer	6.1e-06	6.6e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GSTP1—bone cancer	5.95e-06	6.44e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PTGS2—bone cancer	5.7e-06	6.17e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PTGS2—bone cancer	5.65e-06	6.11e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GSTP1—bone cancer	5.61e-06	6.07e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GSTP1—bone cancer	5.56e-06	6.01e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—EGFR—bone cancer	5.48e-06	5.93e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ENO2—bone cancer	5.45e-06	5.9e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—DHFR—bone cancer	5.06e-06	5.47e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GNA11—bone cancer	4.73e-06	5.12e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTGS2—bone cancer	4.08e-06	4.42e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTP1—bone cancer	3.67e-06	3.97e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTGS2—bone cancer	3.54e-06	3.83e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTGS2—bone cancer	3.16e-06	3.42e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTGS2—bone cancer	3.08e-06	3.34e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTGS2—bone cancer	2.9e-06	3.14e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTGS2—bone cancer	2.88e-06	3.12e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTGS2—bone cancer	1.9e-06	2.05e-05	CbGpPWpGaD
